Media
Category: News
Dipharma Acquires LogixX Pharma, Establishing a Direct Commercial Presence in the United Kingdom
Long-standing UK partner for nitisinone and sapropterin joins the Dipharma Group. Chiasso, Switzerland, November 6, 2026 – Dipharma SA (“Dipharma”), a Swiss specialty pharmaceutical company developing improved medicines for rare diseases, today an...
Dipharma SA ranked #7 among the Top Workplaces in Europe 2025
Chiasso, Switzerland – 21 May 2026 – Dipharma SA, a Swiss pharmaceutical company developing high-quality, improved medicines for rare diseases, is proud to announce that it has been ranked #7 in the Top Workplaces in Europe 2025 list by Best Place...
Interview with PharmaBoardRoom
Founder & CEO Marc-Olivier Geinoz discusses why the company has chosen the largely unexplored rare diseases generics space and the opportunities in metabolic diseases. Marc-Olivier Geinoz – CEO, Dipharma SA Dipharma SA is a Swiss specialty pha...



English
Deutsch